Hypothalamic neurons that contain hypocretin (Orexin) express c-fos during active wakefulness and carbachol-induced active sleep

Sleep Research Online

Volumn 4, Issue 1, 2001, Pages 25-32

  Torterolo, Pablo ^a   Yamuy, Jack ^a   Sampogna, Sharon ^a   Morales, Francisco R ^a   Chase, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; OREXIN; PROTEIN C FOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; CAT; CELL ACTIVITY; CELL COUNT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HYPOTHALAMUS; IMMOBILIZATION STRESS; IMMUNOREACTIVITY; LOCOMOTION; MALE; MICROINJECTION; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SLEEP; SLEEP TIME; WAKEFULNESS;

EID: 0035783234     PISSN: 1096214X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Baghdoyan HA. Cholinergic mechanism regulating REM sleep. In: Schwartz WJ, ed. Sleep Science: integrating basic research and clinical practice. Monographs in clinical neuroscience. Vol 15. Basel: Karger, 1997: 88-116.
2. Berman AL. The brain stem of the cat. A cytoarquitectonic atlas with stereotaxic coordinates. Madison: University of Wisconsin, 1968.
3. Berman AL, Jones EG. The thalamus and basal telencephalum of the cat. A cytoarquitectonic atlas with stereotaxic coordinates. Madison: University of Wisconsin, 1982.
4. Bernardis LL, Bellinger LL. The lateral hypothalamic area revisited: ingestive behavior. Neurosci Biobehav Rev 1996; 20: 189-287.
5. Blake DJ, Gladfelter WE. Wheel-running activity after kainic acid injection into lateral hypothalamus of rats. Physiol Behav 1986; 36: 1009-16.
6. Bourgin P, Huitron-Resendiz S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, de Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000; 20: 7760-5.
7. Chase M, Morales FR. Control of motoneurons during sleep. In: Kryger MH, Roth T and Dement WC, eds. Principles and practices of sleep medicine. Philadelphia: Saunders, 2000: 155-68.
8. Chase MH, Babb M. Masseteric reflex response to reticular stimulation reverses during active sleep compared with wakefulness or quiet sleep. Brain Res 1973; 59: 421-6.
9. Chase MH, Morales FR. The atonia and myoclonia of active (REM) sleep. Annu Rev Psychol 1990; 41: 557-84.
10. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98: 437-51.
11. Cirelli C, Tononi G. On the functional significance of c-fos induction during the sleep-waking cycle. Sleep 2000; 23: 453-69.
12. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 1999; 96: 748-53.
13. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998; 95: 322-7.
14. de Lecea L, Sutcliffe JG. The hypocretins/orexins: novel hypothalamic neuropeptides involved in different physiological systems. Cell Mol Life Sci 1999; 56: 473-80.
15. Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 1989; 29: 261-5.
16. Fung SJ, Yamuy J, Sampogna S, Morales FR, Chase MH. Orexin (hypocretin) input to trigeminal and hypoglossal motoneurons in the cat. Soc Neurosci 2000; 26: 693.
17. Gladfelter WE, Brobeck JR. Decreased spontaneous locomotor activity in the rat induced by hypothalamic lesions. Am J Physiol 1962; 203: 811-17.
18. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah A S , Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA, Upton N. Orexin Aactivates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 1999; 96: 10911-6.
19. Horvath TL, Peyron C, Diano S, Ivanov A, Aston-Jones G, Kilduff TS, van Den Pol AN. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 1999; 415: 145-59.
20. Ida T, Nakahara K, Katayama T, Murakami N, Nakazato M. Effect of lateral cerebroventricular injection of the appetite- stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 1999; 821: 526-9.
21. Ivanov A, Aston-Jones G. Hypocretin/orexin depolarizes and decreases potassium conductance in locus coeruleus neurons. Neuroreport 2000; 11: 1755-8.
22. Jones B. Basic mechanisms of sleep-wake states. In: Kryger MH, Roth T and Dement WC, eds. Principles and practices of sleep medicine. Philadelphia: Saunders, 2000: 134-54.
23. Jones BE. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 1991; 40: 637-56.
24. Kilduff TS, Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 2000; 23: 359-65.
25. Levy DI, Sinnamon HM. Midbrain areas required for locomotion initiated by electrical stimulation of the lateral hypothalamus in the anesthetized rat. Neuroscience 1990; 39: 665-74.
26. Lin JS, Sakai K, Vanni-Mercier G, Jouvet M. Acritical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 1989; 479: 225-40.
27. Marciello M, Sinnamon HM. Locomotor stepping initiated by glutamate injections into the hypothalamus of the anesthetized rat. Behav Neurosci 1990; 104: 980-90.
28. Mondal MS, Nakazato M, Matsukura S. Orexins (hypocretins): novel hypothalamic peptides with divergent functions. Biochem Cell Biol 2000; 78: 299-305.
29. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 1991; 14: 421-51.
30. Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M, Sakurai T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res 2000; 873: 181-7.
31. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999; 827: 243-60.
32. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
33. Nitz D, Siegel JM. GABA release in posterior hypothalamus across sleep-wake cycle. Am J Physiol 1996; 271: R1707-12.
34. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-7.
35. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18: 9996-10015.
36. Piper DC, Upton N, Smith MI, Hunter AJ. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 2000; 12: 726-30.
37. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85.
38. Shekhar A, DiMicco JA. Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats. Neuropharmacology 1987; 26: 407-17.
39. Shiromani PJ, Kilduff TS, Bloom FE, McCarley RW. Cholinergically induced REM sleep triggers Fos-like immunoreactivity in dorsolateral pontine regions associated with REM sleep. Brain Res 1992; 580: 351-7.
40. Siegel JM. Narcolepsy: a key role for hypocretins (orexins). Cell 1999; 98: 409-12.
41. Siegel JM. Basic mechanisms generating REM sleep. In: Kryger MH, Roth T and Dement WC, eds. Principles and practices of sleep medicine. Philadelphia: Saunders, 2000: 112-33.
42. Sinnamon HM. Forelimb and hindlimb stepping by the anesthetized rat elicited by electrical stimulation of the diencephalon and mesencephalon. Physiol Behav 1984; 33: 191-9.
43. Sinnamon HM. Locomotor stepping elicited by electrical stimulation of the hypothalamus persists after lesion of descending fibers of passage. Physiol Behav 1990; 48: 261-6.
44. Sinnamon HM, Ginzburg RN, Kurose GA. Midbrain stimulation in the anesthetized rat: direct locomotor effects and modulation of locomotion produced by hypothalamic stimulation. Neuroscience 1987; 20: 695-707.
45. Sinnamon HM, Lee SH, Adams DB, Stopford CK. Locomotor stepping elicited by electrical stimulation of the lateral hypothalamus requires an ipsilateral descending pathway. Physiol Behav 1984; 33: 209-15.
46. Sinnamon HM, Sklow B. Latency to initiate locomotion elicited by stimulation of the diencephalon positively correlates in awake and anesthetized rats. Pharmacol Biochem Behav 1990; 36: 725-8.
47. Sinnamon HM, Stopford CK. Locomotion elicited by lateral hypothalamic stimulation in the anesthetized rat does not require the dorsal midbrain. Brain Res 1987; 402: 78-86.
48. Steininger TL, Alam MN, Gong H, Szymusiak R, McGinty D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 1999; 840: 138-47.
49. Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000; 62: 161-8.
50. Szymusiak R, Iriye T, McGinty D. Sleep-waking discharge of neurons in the posterior lateral hypothalamic area of cats. Brain Res Bull 1989; 23: 111-20.
51. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-74.
52. van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 1999; 19: 3171-82.
53. Vanni-Mercier G, Sakai K, Jouvet M. [Specific neurons for wakefulness in the posterior hypothalamus in the cat]. C R Acad Sci III 1984; 298: 195-200.
54. Wagner D, Salin-Pascual R, Greco M, Shiromani PJ. Distribution of hypocretin-containing neurons in the lateral hypothalamus and c-fos-immunoreactive neurons in the VLPO. Sleep Res Online 2000; 3: 35-42.
55. Wardas J, Ossowska K, Wolfarth S. Evidence for the independent role of GABAsynapses of the zona incertalateral hypothalamic region in haloperidol-induced catalepsy. Brain Res 1988; 462: 378-82.
56. Yamuy J, Fung SJ, Sampogna S, Morales FR, Chase MH. Orexin (hypocretin)-A and orexin type 1 receptor immunoreactivity in the ventral horn of the cat spinal cord. Soc Neurosci 2000; 26: 2040.
57. Yamuy J, Mancillas JR, Morales FR, Chase MH. C-fos expression in the pons and medulla of the cat during carbachol- induced active sleep. J Neurosci 1993; 13: 2703-18.
58. Zhang JH, Sampogna S, Morales FR, Chase MH. Orexin (hypocretin)-like immunoreactivity in the cat hypothalamus: a light and electron microscopic study. Sleep 2001; 24: 1-10.